Historique
Bulletin de Périodique
Journal of Psychoactive Drugs , Vol.57, n°5 - November-December 2025
Paru le :
01/12/2025
Année
2025
Page(s) :
475-581
Langue(s) :
Anglais
Discipline :
SOM (Sommaire de périodique / Journal contents)
Note de contenu :
CONTENTS:
- Going underground: Demographics, services, and best practices endorsed by practitioners providing support for naturalistic psychedelic use. Glynos N.G., Baker A., Aday J.S., Pouyan N., Barron J., Herberholz M., et al., p. 475-485.
- Inhaled Dimethyltryptamine (DMT): Use patterns and predictors of consumption frequency. Parnes J.E., Earleywine M., p. 486-495.
- Rapid effects of MDMA administration on self-reported personality traits and affect state: A randomized, placebo-controlled trial in healthy adults. Maples-Keller J.L., Hyatt C.S., Phillips N.L., Sharpe B.M., Sherrill A., Yasinski C., et al., p. 496-504.
- Differentiation of ayahuasca samples according to preparation mode and botanical varieties using metabolomics. Matos T.S., da Silva Zandonadi F., Rosini Silva A.A., Dias Soares S., de Souza Lima A., Pastore G.M., et al., p. 505-514.
- Acute psychedelic reactions, post-acute changes in dysfunctional attitudes, and psychedelic-associated changes in wellbeing. Earleywine M., Falabella G.S., Oliva A.B., Low F., p. 515-524.
- Maintenance intramuscular ketamine-assisted psychotherapy, a retrospective chart review of efficacy, adverse events, and dropouts from a community practice. Ryan W.C., Heifets B.D., p. 525-539.
- Fear of COVID-19 diagnosis and cannabis use patterns among adults with chronic health conditions: Results from COVID-19 Cannabis Health Study. Diggs B.A., Baral A., Hlaing W., Pan Y., Camacho-Rivera M., Ortega J., et al., p. 540-549.
- Review and call for improved cannabis measurement and the potential for leveraging cannabis seed-to-sale systems. Wang-Schweig M., Zimmer S., Kirshenbaum A., Mudd L., Slade M., p. 550-560.
- Decriminalizing and legalizing cannabis for clinical benefits in Malaysia: Perspective among pharmacists (a qualitative study). Koh J.A., Loo X.J., Tay J.W., Haw Liew B.Y., Mohammed A.H., Rini R., et al., p. 561-571.
- Positive and negative pathways linking depressive symptoms to problematic alcohol use among Argentinian college students: An examination of positive and negative urgency traits and internal drinking motives. Pilatti A., Correa P., Rivarola Montejano G., Michelini Y., Bravo A.J., Pautassi R.M., p. 572-581.
- Going underground: Demographics, services, and best practices endorsed by practitioners providing support for naturalistic psychedelic use. Glynos N.G., Baker A., Aday J.S., Pouyan N., Barron J., Herberholz M., et al., p. 475-485.
- Inhaled Dimethyltryptamine (DMT): Use patterns and predictors of consumption frequency. Parnes J.E., Earleywine M., p. 486-495.
- Rapid effects of MDMA administration on self-reported personality traits and affect state: A randomized, placebo-controlled trial in healthy adults. Maples-Keller J.L., Hyatt C.S., Phillips N.L., Sharpe B.M., Sherrill A., Yasinski C., et al., p. 496-504.
- Differentiation of ayahuasca samples according to preparation mode and botanical varieties using metabolomics. Matos T.S., da Silva Zandonadi F., Rosini Silva A.A., Dias Soares S., de Souza Lima A., Pastore G.M., et al., p. 505-514.
- Acute psychedelic reactions, post-acute changes in dysfunctional attitudes, and psychedelic-associated changes in wellbeing. Earleywine M., Falabella G.S., Oliva A.B., Low F., p. 515-524.
- Maintenance intramuscular ketamine-assisted psychotherapy, a retrospective chart review of efficacy, adverse events, and dropouts from a community practice. Ryan W.C., Heifets B.D., p. 525-539.
- Fear of COVID-19 diagnosis and cannabis use patterns among adults with chronic health conditions: Results from COVID-19 Cannabis Health Study. Diggs B.A., Baral A., Hlaing W., Pan Y., Camacho-Rivera M., Ortega J., et al., p. 540-549.
- Review and call for improved cannabis measurement and the potential for leveraging cannabis seed-to-sale systems. Wang-Schweig M., Zimmer S., Kirshenbaum A., Mudd L., Slade M., p. 550-560.
- Decriminalizing and legalizing cannabis for clinical benefits in Malaysia: Perspective among pharmacists (a qualitative study). Koh J.A., Loo X.J., Tay J.W., Haw Liew B.Y., Mohammed A.H., Rini R., et al., p. 561-571.
- Positive and negative pathways linking depressive symptoms to problematic alcohol use among Argentinian college students: An examination of positive and negative urgency traits and internal drinking motives. Pilatti A., Correa P., Rivarola Montejano G., Michelini Y., Bravo A.J., Pautassi R.M., p. 572-581.
Cote :
Abonnement